In theory, ribonucleic acid (RNA) is an ideal diagnostic biomarker. Because cellular transcription dynamically shifts in response to disease, sequencing the RNA circulating in a patient's bodily fluids could provide a real-time, non-invasive window into their health.
In practice, however, the bloodstream is a hostile environment for nucleic acids. It is teeming with ribonucleases (RNases)—specifically exonucleases—that rapidly bind to and chew up free-floating RNA molecules. As observed by Lei Kang et al. in Noninvasive Visualization of RNA Delivery with 99mTc-Radiolabeled Small-Interference RNA in Tumor Xenografts, standard single-stranded linear RNAs are highly unstable in circulation due to this enzymatic degradation. This fragility creates a fundamental engineering challenge for liquid biopsies: how can a diagnostic signal be maintained when the target molecules naturally decompose within minutes?
To overcome this barrier, researchers are leveraging two distinct mechanisms that grant extracellular RNA remarkable resistance to exonucleases: topological circularization and vesicular encapsulation. By understanding why these structures survive, clinicians can isolate highly stable, tissue-specific genetic signals from simple blood or urine draws.
The Topological Solution: Covalent Circularization
To understand why circular RNAs (circRNAs) resist degradation, consider the mechanical action of an exonuclease. Most cellular exonucleases require a free end—either a 5' or 3' terminus—to bind a nucleic acid strand and begin digesting it nucleotide by nucleotide.
Imagine a piece of thread versus a rubber band. A pair of scissors designed only to cut from the loose ends of a thread will be completely ineffective against a continuous, closed loop.
Linear RNA (Vulnerable):
5' ───[Exonuclease Attacks Here]───> 3'
Circular RNA (Protected):
┌───────┐
│ │ <─── No free ends for exonuclease binding
└───────┘
This is the exact structural advantage of circRNAs. Formed through a non-canonical splicing event known as "back-splicing," the 5' and 3' ends of the transcript are covalently joined together. As Guifang Xu et al. note in Circular RNA CCDC66 promotes gastric cancer progression by regulating c-Myc and TGF-β signaling pathways, this closed-loop topology provides exceptional resistance to enzymatic cleavage. While linear transcripts are rapidly cleared from circulation, circRNAs accumulate and remain intact, as highlighted by Yonggang Zhang et al. in circCRAMP1L is a novel biomarker of preeclampsia risk and may play a role in preeclampsia pathogenesis via regulation of the MSP/RON axis in trophoblasts.
This topological resilience is not just a biological curiosity; it is a powerful tool for biomarker discovery. In the laboratory, researchers can intentionally treat biofluid samples with RNase R, a highly active exonuclease. Because RNase R aggressively degrades linear RNAs while leaving closed loops untouched, this process acts as a biochemical filter. As demonstrated by Ziwei Li et al. in Intron Lariat RNA Inhibits MicroRNA Biogenesis by Sequestering the Dicing Complex in Arabidopsis and Xiaying Zheng et al. in The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer, treating RNA-seq libraries with RNase R allows for the high-throughput isolation, identification, and quantification of stable circularized biomarkers that would otherwise be lost in background genetic noise.
The Physical Solution: Vesicular Encapsulation
What happens to linear RNAs, such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), which lack this topological protection? To survive circulation, they rely on physical shielding.
Cells routinely package these fragile linear molecules into extracellular vesicles (EVs), such as exosomes. These nano-sized, lipid-bilayer "mail carriers" physically isolate their internal cargo from the external environment. As explained by Yujuan Dong et al. in MicroRNA dysregulation in colorectal cancer: a clinical perspective, packaging small RNAs within these vesicles or complexing them with protective proteins shields them from enzymatic attack.
The authors of Long noncoding RNAs in digestive system cancers: Functional roles, molecular mechanisms, and clinical implications (Review), led by Min Fu, show that this encapsulation allows otherwise unstable lncRNAs to remain perfectly intact within harsh extracellular environments like blood or gastric juices. The lipid membrane acts as a literal wall, preventing RNases from ever coming into contact with the vulnerable phosphodiester backbone of the linear RNA cargo.
A Non-Invasive Window into Remote Tissues
By targeting either topologically protected circRNAs or physically shielded exosomal RNAs, researchers can bypass the problem of biomarker degradation entirely. This stability turns peripheral biofluids into highly reliable diagnostic archives.
To organize these stable signals, Hongyan Lai et al. developed exoRBase 2.0: an atlas of mRNA, lncRNA and circRNA in extracellular vesicles from human biofluids, mapping how these protected molecules can be systematically tracked across human diseases.
Because these protected RNAs reflect the precise physiological state of their cells of origin, they allow clinicians to safely sample tissues that are otherwise difficult or dangerous to biopsy:
- The Brain: Extracellular vesicles released by central nervous system cells can cross the blood-brain barrier into peripheral blood. As shown by Maria Bregendahl et al. in 369 Differentiating Dementia with Lewy Bodies and Alzheimer’s Disease Using Extracellular Vesicles, isolating these brain-derived vesicles from a simple blood draw allows for the non-invasive profiling of neurodegenerative diseases.
- The Kidneys: Rather than performing an invasive needle biopsy of renal tissue, clinicians can look to urine. Wei Zhu et al. demonstrated in miR-148b-5p regulates hypercalciuria and calcium-containing nephrolithiasis that urinary exosomes serve as a reliable, non-invasive proxy for renal tissue, encapsulating pristine miRNA profiles that mirror the metabolic and pathological state of the kidney tubules.
Ultimately, the very mechanisms that biology evolved to facilitate stable, long-distance cellular communication—covalent circularization and vesicle encapsulation—provide the exact structural solutions required to make liquid biopsies a clinical reality.